Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
LAVAL, QC / ACCESSWIRE / October 9, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2024 financial...
Pharmaceutical
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation...
Parcel Health(R) Offers Safer, Sustainable Paper Pill Bottles for Affordable Obesity Treatment
Parcel Health aims to continue to provide sustainable paper pill bottles to divert plastic from the waste stream and help...
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization...
Healthcare Analytics Market to Hit USD 133.19 Billion by 2029 with 24.3% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Oct. 9, 2024 /PRNewswire/ -- The global Healthcare Analytics market is expected to grow significantly, reaching USD 133.19...
Every Cure Receives Five-Year, $60 Million Commitment Through TED’s Audacious Project to Repurpose Medications for Global Impact
PHILADELPHIA, Oct. 9, 2024 /PRNewswire/ -- Every Cure, an AI-powered nonprofit biotech organization, has received a five-year $60 million commitment through...
ProofPilot Welcomes Roslyn Schneider to Advisory Board
NEW YORK, Oct. 9, 2024 /PRNewswire/ -- ProofPilot, the industry's first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and...
BuzzRx® Unveils Insights From New “State of Our Health” Data Report
In-Depth Exploration of Five Key Topics for October's Awareness Month Themes FORT LAUDERDALE, Fla., Oct. 9, 2024 /PRNewswire/ -- BuzzRx,...
Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy
Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art FREMONT, Calif., Oct. 9,...
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ -- ProPharma,...
Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and...
Lexaria’s GLP-1 Human Pilot Study #3 Begins Dosing
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024...
MedCana Highlights Recent Acquisitions and the Multiple Cannabis Licenses Associated with Each
The licenses will add $1.6 million to our total Assets for the 3rd Quarter. AUSTIN, TX / ACCESSWIRE / October...
180 Life Sciences Corp. Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Rule and Expands into the Global iGaming Sector
PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is...
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients NOTTINGHAM, ENGLAND / ACCESSWIRE / October...
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Releaf® Announces Partnership with SOMAÍ Pharmaceuticals to Bring Innovative Cannabis Solutions to UK Patients NOTTINGHAM, ENGLAND / ACCESSWIRE / October...
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and...
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
Sonnet to receive $1.0 million in upfront payment and up to an additional$1.0 million in milestone payments with a royalty...
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development
DOYLESTOWN, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical...